Universal Asset Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Universal asset management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Universal Asset Management Today - Breaking & Trending Today

REGENXBIO (NASDAQ:RGNX) Stock Price Down 5%

REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report)’s stock price traded down 5% on Monday . The stock traded as low as $13.22 and last traded at $13.38. 322,961 shares were traded during trading, a decline of 48% from the average session volume of 622,212 shares. The stock had previously closed at $14.08. Analyst Ratings Changes […] ....

United States , Raymond James , Robertw Baird , Technology Platform , Regenxbio Inc , Goldman Sachs Group , China Universal Asset Management Co , Royal Bank , Annandale Capital , Allspring Global Investments Holdings , Company Profile , Headlands Technologies , Financial Services Group Inc , Get Free Report , Services Group , Global Investments Holdings , China Universal Asset Management , Universal Asset Management ,

Savara (NASDAQ:SVRA) Shares Up 6.1%

Savara Inc (NASDAQ:SVRA – Get Free Report) shot up 6.1% on Monday . The company traded as high as $4.22 and last traded at $4.20. 271,525 shares traded hands during trading, a decline of 69% from the average session volume of 883,007 shares. The stock had previously closed at $3.96. Analysts Set New Price Targets […] ....

Piper Sandler , Principal Financial Group Inc , Tower Research Capital , Savara Company Profile , Mast Therapeutics Inc , Canada Life Assurance , Savara Inc , China Universal Asset Management Co , Get Free Report , Stock Down , Financial Group , Universal Asset Management , Research Capital , Mast Therapeutics , Savara Daily ,

Hesai Group (NASDAQ:HSAI) Stock Price Up 6.6%

Shares of Hesai Group (NASDAQ:HSAI – Get Free Report) rose 6.6% on Monday . The company traded as high as $5.03 and last traded at $5.03. Approximately 364,273 shares traded hands during trading, a decline of 52% from the average daily volume of 760,711 shares. The stock had previously closed at $4.72. Hesai Group Price […] ....

Entrypoint Capital , Hesai Group Company Profile , Hesai Group , China Universal Asset Management Co , Hesai Group Price Performance , News Ratings For Hesai Group Daily , Nomura Holdings Inc , Psagot Value Holdings Ltd , Susquehanna Fundamental Investments , Get Free Report , Value Holdings , Point Capital , Universal Asset Management , Fundamental Investments , Nomura Holdings , Hesai Group Daily ,

Frazier Life Sciences Management L.P. Grows Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […] ....

United States , Stifel Nicolaus , Eric Bjerkholt , Saira Ramasastry , News Ratings For Mirum Pharmaceuticals Daily , Wetzel Investment Advisors Inc , Quest Partners , China Universal Asset Management Co , Stepstone Group , Insider Transactions At Mirum Pharmaceuticals , Quarter For Mirum Pharmaceuticals , Morgan Stanley , Mirum Pharmaceuticals Stock Down , Mirum Pharmaceuticals , Cantor Fitzgerald , Exchange Commission , Frazier Life Sciences Management , Mirum Pharmaceuticals Profile , Mirum Pharmaceuticals Inc , Free Report , Investment Advisors , Stone Group , Universal Asset Management , Director Saira Ramasastry , Pharmaceuticals Stock Down , Get Free Report ,

Frazier Life Sciences Management L.P. Invests $15.76 Million in Dyne Therapeutics, Inc. (NASDAQ:DYN)

Frazier Life Sciences Management L.P. bought a new position in Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,184,840 shares of the company’s stock, valued at approximately $15,758,000. Frazier Life Sciences Management L.P. owned 1.93% of Dyne Therapeutics at […] ....

United States , Oxana Beskrovnaya , Stifel Nicolaus , Dyne Therapeutics Inc , China Universal Asset Management Co , Morgan Stanley , Sg Americas Securities , Frazier Life Sciences Management , Jefferies Financial Group , Corton Capital Inc , Principal Financial Group Inc , Profund Advisors , Dyne Therapeutics , Free Report , Universal Asset Management , Financial Group , Gatti High , Get Free Report , Visit Holdingschannel , Dyne Therapeutics Daily ,